Related Experiment Video
Updated: Jan 21, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Secular Trends in Procedural Stroke or Death Risks of Stenting Versus Endarterectomy for Symptomatic Carotid Stenosis
Mandy D Müller1, Stefanie von Felten2, Ale Algra3
1Department of Neurology and Stroke Center (M.D.M. and L.H.B.), University Hospital Basel, University of Basel, Switzerland.
Insights
Procedural stroke or death risk decreased significantly for carotid endarterectomy but not for carotid artery stenting. Carotid endarterectomy showed a sustained lower risk over time compared to stenting.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Neurology
Background:
- Stroke risk in carotid disease has decreased due to improved medical therapy and vascular risk factor control.
- The procedural risks associated with carotid revascularization over time remain less clear.
Purpose of the Study:
- To analyze temporal changes in procedural risks for carotid artery stenting versus carotid endarterectomy.
- To compare the stroke or death risk between carotid endarterectomy and stenting over time.
Main Methods:
- Analysis of 4597 patients with symptomatic carotid stenosis from 4 randomized trials (2000-2008).
- Patients were treated with either carotid artery stenting or carotid endarterectomy.
- Generalized linear mixed-effects models were used to assess temporal trends in procedural stroke or death risk.
Main Results:
- Overall procedural stroke or death risk significantly decreased over time (OR per year, 0.91).
- This decrease was driven by carotid endarterectomy (OR per year, 0.82), with no significant change for carotid artery stenting (OR, 0.96).
- Carotid endarterectomy had a lower procedural risk than stenting, and this difference widened over time (interaction P=0.031).
Conclusions:
- Procedural stroke or death risk for carotid endarterectomy in symptomatic carotid stenosis decreased over 8 years.
- No similar reduction in procedural risk was observed for patients treated with carotid artery stenting.
- Carotid endarterectomy demonstrated a progressively lower procedural risk compared to stenting.
Background:
Over the past decades, stroke risk associated with carotid disease has decreased, reflecting improvements in medical therapy and a more rigorous control of vascular risk factors. It is less clear whether the procedural risk of carotid revascularization has declined over time.
Methods:
We analyzed temporal changes in procedural risks among 4597 patients with symptomatic carotid stenosis treated with carotid artery stenting (n=2326) or carotid endarterectomy (n=2271) in 4 randomized trials between 2000 and 2008, using generalized linear mixed-effects models with a random intercept for each source trial. Models were additionally adjusted for age and other baseline characteristics predicting treatment risk. The primary outcome event was any procedural stroke or death, occurring during or within 30 days after revascularization.
Results:
The procedural stroke or death risk decreased significantly over time in all patients (unadjusted odds ratio per year, 0.91; 95% CI, 0.85-0.97; P=0.006). This effect was driven by a decrease in the carotid endarterectomy group (unadjusted odds ratio per year, 0.82; 95% CI, 0.73-0.92; P=0.003), whereas no significant decrease was found after carotid artery stenting (unadjusted odds ratio, 0.96; 95% CI, 0.88-1.04; P=0.33). Carotid endarterectomy patients had a lower procedural stroke or death risk compared with carotid artery stenting patients, and the difference significantly increased over time (interaction P=0.031). After adjustment for baseline characteristics, the results remained essentially the same.
Conclusions:
The risk of stroke or death associated with carotid endarterectomy for symptomatic carotid stenosis decreased over an 8-year period, independent of clinical predictors of procedural risk. No corresponding reduction in procedural risk was seen in patients treated with stenting.
Clinical Trial Registration:
URL: https://www.clinicaltrials.gov; http://www.isrctn.com. Unique identifier: NCT00190398 (EVA-3S), NCT00004732 (CREST), ISRCTN57874028 (SPACE), and ISRCTN25337470 (ICSS).
More Related Videos
08:26Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis
Published on: January 21, 2020
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
Related Concept Videos
Current Trends in Nursing I
Current Trends in Nursing II
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Mitral Stenosis I: Introduction
Relative Risk
Trends in Lattice Energy: Ion Size and Charge